Literature DB >> 23674003

Intranodal cystic changes: a potential radiologic signature/biomarker to assess the human papillomavirus status of cases with oropharyngeal malignancies.

Ajaykumar C Morani1, Avraham Eisbruch, Thomas E Carey, Samantha J Hauff, Heather M Walline, Suresh K Mukherji.   

Abstract

OBJECTIVE: The aim of this study was to determine if lymph node imaging findings can predict human papillomavirus (HPV) positivity in oropharyngeal squamous cell cancers. METHODS AND MATERIALS: Pretreatment postcontrast neck computed tomographic scans of 49 patients (male, 35; female, 14; age range, 45-76 years) diagnosed with oropharyngeal malignancies and with available HPV data were retrospectively reviewed. Metastatic lymph nodes were identified based on standardly accepted size and morphological criteria. Various lymph node parameters were studied, including presence of cystic foci in the metastatic lymph nodes, abnormal lymph nodes showing low-attenuation foci, matted lymph nodes, and morphologically normal smaller (<1.5 cm) lymph nodes. These parameters were then independently correlated with the available HPV status of these patients. Finally, an extended criterion, that is, intranodal cystic changes in cases with morphologically normal small (<1.5 cm) lymph nodes, was correlated with HPV status. Sensitivity, specificity, and positive predictive values (PPVs) and negative predictive values (NPVs) were calculated.
RESULTS: Of these 49 cases with oropharyngeal cancers, 27 were HPV positive, and 22 cases were HPV negative. Eight cases (3 HPV positive and 5 HPV negative) did not have metastatic lymph nodes. Of remaining 41 cases with metastatic abnormal lymph nodes, 26 were HPV positive, and 15 were HPV negative. Of these 41 cases with metastatic lymph nodes, 14 had 1 or more lymph nodes with cystic foci. Of these 14 cases, 10 (71.4%) were HPV positive. Resultant sensitivity, specificity, PPV, and NPV of cystic foci for the presence of HPV status were 38.4%, 73.3%, 71.4%, and 40.7%, respectively. Intranodal cystic changes in cases with morphologically normal small (<1.5 cm) lymph nodes were found in 5 cases; all 5 were HPV positive. Resultant accuracy was specificity and PPV of 100%, sensitivity of 19.2% and NPV of 41.6%.
CONCLUSIONS: Intranodal cystic changes seen on the pretreatment postcontrast neck computed tomographic scan of patients with oropharyngeal malignancies are radiologic signatures strongly associated with the HPV status of the patient. The results in this initial study warrant larger prospective studies to determine if this finding may be used in addition to other molecular biomarkers to help identify those patients who may be amenable to the most appropriate treatment options.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23674003      PMCID: PMC3658148          DOI: 10.1097/RCT.0b013e318282d7c3

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  22 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Do all patients with head and neck cancer benefit from radiotherapy and concurrent cetuximab?

Authors:  Jesper Grau Eriksen; Pernille Lassen; Jens Overgaard
Journal:  Lancet Oncol       Date:  2010-04       Impact factor: 41.316

3.  HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors.

Authors:  Monique C de Jong; Jimmy Pramana; Joost L Knegjens; Alfons J M Balm; Michiel W M van den Brekel; Michael Hauptmann; Adrian C Begg; Coen R N Rasch
Journal:  Radiother Oncol       Date:  2010-03-24       Impact factor: 6.280

Review 4.  Human Papilloma Virus (HPV) in head and neck region: review of literature.

Authors:  L Mannarini; V Kratochvil; L Calabrese; L Gomes Silva; P Morbini; J Betka; M Benazzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-06       Impact factor: 2.124

Review 5.  Clinical implications of human papillomavirus in head and neck cancers.

Authors:  Carole Fakhry; Maura L Gillison
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

6.  Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon.

Authors:  David Goldenberg; Shahnaz Begum; William H Westra; Zubair Khan; James Sciubba; Sara I Pai; Joseph A Califano; Ralph P Tufano; Wayne M Koch
Journal:  Head Neck       Date:  2008-07       Impact factor: 3.147

7.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

8.  Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas.

Authors:  Harriët C Hafkamp; J J Manni; A Haesevoets; A C Voogd; M Schepers; F J Bot; A H N Hopman; F C S Ramaekers; Ernst-Jan M Speel
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

9.  Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience.

Authors:  Kim Huang; Ping Xia; Cynthia Chuang; Vivian Weinberg; Christine M Glastonbury; David W Eisele; Nancy Y Lee; Sue S Yom; Theodore L Phillips; Jeanne M Quivey
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

10.  Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus.

Authors:  Divya A Patel; Yang-Jen Shih; Duane W Newton; Claire W Michael; Paul A Oeth; Michael D Kane; Anthony W Opipari; Mack T Ruffin; Linda M Kalikin; David M Kurnit
Journal:  J Virol Methods       Date:  2009-05-03       Impact factor: 2.014

View more
  9 in total

1.  Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy response.

Authors:  Chad Tang; Clifton D Fuller; Adam S Garden; Musaddiq J Awan; Rivka R Colen; William H Morrison; Steven J Frank; Beth M Beadle; Jack Phan; Erich M Sturgis; Mark E Zafereo; Randal S Weber; David I Rosenthal; G Brandon Gunn
Journal:  Oral Oncol       Date:  2014-11-28       Impact factor: 5.337

2.  Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.

Authors:  T J Rath; S Narayanan; M A Hughes; R L Ferris; S I Chiosea; B F Branstetter
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-27       Impact factor: 3.825

Review 3.  Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

Authors:  Travis C Salzillo; Nicolette Taku; Kareem A Wahid; Brigid A McDonald; Jarey Wang; Lisanne V van Dijk; Jillian M Rigert; Abdallah S R Mohamed; Jihong Wang; Stephen Y Lai; Clifton D Fuller
Journal:  Semin Radiat Oncol       Date:  2021-10       Impact factor: 5.421

Review 4.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Oropharynx and Nasopharynx.

Authors:  Cécile Badoual
Journal:  Head Neck Pathol       Date:  2022-03-21

5.  Comparison of Imaging Findings between Human Papillomavirus-positive and -Negative Squamous Cell Carcinomas of the Maxillary Sinus.

Authors:  Masaya Kawaguchi; Hiroki Kato; Hiroyuki Tomita; Akira Hara; Natsuko Suzui; Tatsuhiko Miyazaki; Masayuki Matsuo
Journal:  J Clin Imaging Sci       Date:  2020-10-01

6.  The impact of radiomics for human papillomavirus status prediction in oropharyngeal cancer: systematic review and radiomics quality score assessment.

Authors:  Gaia Spadarella; Lorenzo Ugga; Giuseppina Calareso; Rossella Villa; Serena D'Aniello; Renato Cuocolo
Journal:  Neuroradiology       Date:  2022-04-23       Impact factor: 2.995

7.  Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.

Authors:  Yu-Han Huang; Chih-Hua Yeh; Nai-Ming Cheng; Chien-Yu Lin; Hung-Ming Wang; Sheung-Fat Ko; Cheng-Hong Toh; Tzu-Chen Yen; Chun-Ta Liao; Shu-Hang Ng
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

8.  Radiological differences in computed tomography findings and texture analysis between cystic lymph node metastases of human papillomavirus-positive oropharyngeal cancer and second branchial cysts.

Authors:  Akira Baba; Hisashi Kessoku; Ryo Kurokawa; Hideomi Yamauchi; Taisuke Akutsu; Eiji Shimura; Koshi Ikeda; Hiroya Ojiri
Journal:  Pol J Radiol       Date:  2021-03-25

9.  Prognostic Value of Apparent Diffusion Coefficient in Oropharyngeal Carcinoma.

Authors:  Heli J Sistonen; Katri Aro; Timo Atula; Lauri Jouhi; Riikka Lindén; Laura Tapiovaara; Venla Loimu; Antti Markkola
Journal:  Clin Neuroradiol       Date:  2021-04-20       Impact factor: 3.649

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.